Opiant Pharmaceuticals (OPNT) Posts Wider Q1 Loss
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Financial Fact:
Diluted weighted average common shares outstanding: 22.92M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Diluted weighted average common shares outstanding: 22.92M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q1 EPS of ($2.43), $1.52 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $4.5 million versus the consensus estimate of $5.9 million.
For earnings history and earnings-related data on Opiant Pharmaceuticals (OPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- LTC Properties (LTC) PT Raised to $52 at RBC Capital
- Forgent Power Solutions jumps as Bernstein sees massive earnings upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
